Desentis-Vargas E, Zavala-Habib A, Blandón-Vijil MV

Language: Spanish
References: 25
Page: 165-171
PDF size: 416.87 Kb.

ABSTRACT

Background: Systemic steroids are an effective pharmacological tool in diverse otolaryngological conditions.
Objetive: To know real life conditions at clinical and surgical level where systemic steroids are used by otolaryngologists in Mexico.
Material and Method: A survey was conducted among Mexican Otolaryngologists who attended the 2013 medical congress of the Federación Mexicana de Otorrinolaringología y Cirugía de Cabeza y Cuello, AC.
Results: A total of 163 surveys were collected; 98% (n = 160) otolaryngologists answered that they prescribe systemic steroids in their clinical and surgical practice. The main conditions for which they prescribe systemic steroids were asthma exacerbations (n = 109, 67%), acute laryngitis (n = 107, 66%) and chronic rhinosinusitis with polyps (n = 106, 65%); 31% (50) of otolaryngologists referred the duration of use of such medications for 6 to 10 days on average. The main reason for both pre-surgical (70%) and post-surgical (50%) usage was chronic rhinosinusitis with polyps. The main type of steroid used according to potency was short acting; 72% (n = 118) did not observe adverse events related to systemic use.
Conclusions: Systemic steroids are important tool of anti-inflammatory therapy for otolaryngological conditions. The use was due to acute or chronic reasons.

REFERENCES

1. Rimmer J, Fokkens W, Chong LY, Hopkins C. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev 2014;12:CD006991.

2. Hobson CE, Alexander TH, Harris JP. Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone. Curr Opin Otolaryngol Head Neck Surg 2016;24(5):407-12. doi: 10.1097/MOO

3. Kuthubutheen J, Coates H, Rowsell C, Nedzelski J, Chen JM, Lin V. The role of extended preoperative steroids in hearing preservation cochlear implantation. Hear Res 2015 Sep;327:257-64. doi: 10.1016/j.heares.2015.06.010.

4. Schacke H, Docke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticoids Pharmacol Ther 2002;96:23-43.

5. Gutiérrez-Farfán I, Ramírez-Vargas M, Mena-Ayala J. Hallazgos audiológicos en pacientes con hipoacusia súbita manejados con esteroides y extracto de ginkgo biloba. An ORL Mex 1998;43:144-7.

6. Rauch SD, Halpin CF, Antonelli PJ and cols. Oral and intratympanic corticosteroid therapy are equally effective for the treatment of sudden sensorineural hearing loss. JAMA 2011;305(20):2071-9.

7. Curiel DC, Garduño AM, González HC. Perfusión del oído interno con dexametasona y prednisona oral en la hipoacusia súbita neurosensorial unilateral idiopática como tratamiento combinado. Otorrinolaringología 2012;57:196-204.

8. De la Garza-Hesles H, Camacho-Rivera CI, Esteinou-Madrid C. Comparación entre la aplicación intratimpánica y la administración sistémica de esteroide para el tratamiento de pacientes con hipoacusia súbita. Otorrinolaringología 2015;60:61-68.

9. Kowalski ML. Oral and nasal steroids for nasal polyps. Curr Allergy Asthma Rep 2011;11:187-188.

10. Alobid I, Benitez P, Pujols L and cols. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinol 2006;44:8-13.

11. Holland NJ, Weiner GM. Recent developments in Bell’s palsy. BMJ 2004;329:553-7.

12. Ramsey MJ, DerSimonian R, Holtel MR, Burgess LPA. Corticosteroid treatment for idiopathic facial nerve paralysis: A Meta-analysis. Laryngoscope 2000;110:335-341.

13. Flores-Flores P, Medina-Zazueta R, Haro-García L. Tratamiento de la parálisis facial periférica idiopática: terapia física versus prednisona. Rev Med IMSS 1998;36:217-221.

14. Martínez C, Abarca B, Alvarado CL, Almonte C, Acevedo M, Leyton R. Parálisis de Bell: evaluación del tratamiento esteroidal. Bol Hosp San Juan de Dios 1990;37:13-17.

15. Brosens C, Botargues M. ¿Son útiles los corticoides y los antivirales en el tratamiento de la parálisis facial idiopática? Evidencia Actualización en la Práctica Ambulatoria 2008;11:124-125.

16. Chi-Chan A, Couto y Arcos F; Martín-Biasotti F, Bross- Soriano D; Vázquez-Valle M. Esteroides orales en la preparación preoperatoria de poliposis nasal. An ORL Mex 1996;41:155-60.

17. Sakallioğlu Ö, Polat C, Soylu E, Düzer S, Orhan İ, Akyiğit A. The efficacy of tranexamic acid and corticosteroid on edema and ecchymosis in septorhinoplasty. Ann Plast Surg 2015;74:392-6.

18. Saedi B, Sadeghi M, Fekri K. Comparison of the effect of corticosteroid therapy and decongestant on reducing rhinoplasty edema. Am J Rhinol Allergy 2011;25:e141-4.

19. Taskin U, Yigit O, Bilici S, Kuvat SV, Sisman AS, Celebi S. Efficacy of the combination of intraoperative cold saline-soaked gauze compression and corticosteroids on rhinoplasty morbidity. Otolaryngol Head Neck Surg 2011;144:698-702.

20. Snäll J, Kormi E, Lindqvist C, et al. Impairment of wound healing after operative treatment of mandibular fractures, and the influence of dexamethasone. Br J Oral Maxillofac Surg 2013;51:808-12.

21. Thorén H, Snäll J, Kormi E, et al. Does perioperative glucocorticosteroid treatment correlate with disturbance in surgical wound healing after treatment of facial fractures? A retrospective study. J Oral Maxillofac Surg 2009;67:1884-8.

22. Cuevas M, Zahnert T. Chronic rhinosinusitis. Laryngorhinootologie 2015;94:395-414.

23. Shikani AH, Chahine KA, Alqudah MA. Rhinotopic therapy for refractory chronic rhinosinusitis: a study of 20 cases. Ear Nose Throat J 2014 Apr-May;93(4-5):E48-54.

24. Nakayama T, Asaka D, Kanaya H, Kuboki A, Haruna SI. Prognostic factors for recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Auris Nasus Larynx 2016;43(6)Dec:641-647.

25. Wang H, Wright CD, Wain JC, Ott HC, Mathisen DJ. Idiopathic subglottic stenosis: factors affecting outcome after single-stage repair. Ann Thorac Surg 2015;100:1804-11.